Integrating Rapid Lymphoma Next-Generation Sequencing Panel-Based Testing into Routine Genomic Diagnostics
Annals of Laboratory Medicine · 01.05.2026 · 46 (3) · 241-243
DOI: 10.3343/alm.2026.0150 ↗Kurz gefasst
Editorial in der Zeitschrift Annals of Laboratory Medicine, online erschienen am 07.04.2026. Verfasst von Saeam Shin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
the Ion Torrent Genexus Integrated Se-quencer (Thermo Fisher Scientific). The IALLNP is a commercially available amplicon-based DNA sequencing assay that targets 60 clinically relevant genes, including the complete coding regions of 17 genes and selected exonic hotspots in 43 genes recurrently mutated in lymphoid malignancies. The panel detects single-nucleotide variants (SNVs) and small insertions/deletions (indels).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
ORCID-Profile: Saeam Shin, Seung-Tae Lee
Zitieren
APA
Shin, S., & Lee, S. T. (2026). Integrating Rapid Lymphoma Next-Generation Sequencing Panel-Based Testing into Routine Genomic Diagnostics. Annals of Laboratory Medicine, 46(3), 241-243. https://doi.org/10.3343/alm.2026.0150
Vancouver
Shin S, Lee ST. Integrating Rapid Lymphoma Next-Generation Sequencing Panel-Based Testing into Routine Genomic Diagnostics. Annals of Laboratory Medicine. 2026;46(3):241-243. doi:10.3343/alm.2026.0150
BibTeX
@article{Shin2026,
author = {Shin, Saeam and Lee, Seung-Tae},
title = {Integrating Rapid Lymphoma Next-Generation Sequencing Panel-Based Testing into Routine Genomic Diagnostics},
journal = {Annals of Laboratory Medicine},
year = {2026},
volume = {46},
number = {3},
pages = {241--243},
doi = {10.3343/alm.2026.0150}
}
EUVIMED